(E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like…

Overview of attention for article published in Frontiers in Pharmacology, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 78,476 followers.

RT @FrontPharmacol: New Research: (E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPB…

06 Dec 2021

Reply Repost Favourite

(E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating... (Kudova, Pavek) - @FrontPharmacol: https://t.co/KLhzLjIV8T @IOCBPr

19 Oct 2021

Reply Repost Favourite

RT @DanielJDrucker: Remarkably, a dual FXR and GPBAR1 agonist is proposed as a therapeutic approach for Rxment of #T1D @FrontiersIn https:/…

06 Sep 2021

Reply Repost Favourite

Remarkably, a dual FXR and GPBAR1 agonist is proposed as a therapeutic approach for Rxment of #T1D @FrontiersIn https://t.co/qeyePpEHsj

06 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.